Dysferlin is a new marker for leaky brain blood vessels in multiple sclerosis

被引:123
|
作者
Hochmeister, Sonja
Grundtner, Roland
Bauer, Jan
Engelhardt, Britta
Lyck, Ruth
Gordon, Grace
Korosec, Thomas
Kutzelnigg, Alexandra
Berger, Johannes J.
Bradl, Monika
Bittner, Reginald E.
Lassmann, Hans
机构
[1] Med Univ Vienna, Ctr Brain Res, Div Neuroimmunol, A-1090 Vienna, Austria
[2] Med Univ Vienna, Ctr Anat & Cell Biol, A-1090 Vienna, Austria
[3] Univ Bern, Theodor Kocher Inst, CH-3012 Bern, Switzerland
来源
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY | 2006年 / 65卷 / 09期
关键词
blood-brain barrier; endothelial cells; experimental autoimmune encephalomyelitis (EAE); inflammation; leakage; marker; multiple sclerosis;
D O I
10.1097/01.jnen.0000235119.52311.16
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Dysferlin is a muscle protein involved in cell membrane repair and its deficiency is associated with muscular dystrophy. We describe that dysferlin is also expressed in leaky endothelial cells. In the normal central nervous system (CNS), dysferlin is only present in endothelial cells of circumventricular organs. In the inflamed CNS of patients with multiple sclerosis (MS) or in animals with experimental autoimmune encephalomyclitis, dysferlin reactivity is induced in endothelial cells and the expression is associated with vascular leakage of serum proteins. In MS, dysferlin expression in endothelial cells is not restricted to vessels with inflammatory cuffs but is also present in noninflamed vessels. In addition, many blood vessels with perivascular inflammatory infiltrates lack dysferlin expression in inactive lesions or in the normal-appearing white matter. In vitro, dysferlin can be induced in endothelial cells by stimulation with tumor necrosis factor-alpha. Hence, dysferlin is not only a marker for leaky brain vessels, but also reveals dissociation of perivascular inflammatory infiltrates and blood-brain barrier disturbance in multiple sclerosis.
引用
收藏
页码:855 / 865
页数:11
相关论文
共 50 条
  • [1] Dysferlin as a marker for blood brain barrier damage
    Hochmeister, S
    Kutzelnigg, A
    Lassmann, H
    JOURNAL OF NEUROLOGY, 2005, 252 : 38 - 38
  • [2] THE PATHOLOGY OF THE BLOOD VESSELS IN MULTIPLE SCLEROSIS
    MACCHI, G
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1954, 13 (02): : 378 - 384
  • [3] Leaky Blood Vessels in the Brain Linked to Brain Fog in Long COVID Patients
    Genetic Engineering and Biotechnology News, 2024, 44 (04): : 10
  • [4] Blood vessels within brain lesions of patients with multiple sclerosis (MS) are highly adhesive for blood lymphocytes
    Vora, AJ
    Newcombe, J
    Cuzner, ML
    Brown, KA
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1996, 22 (05) : 450 - 450
  • [5] Gadolinium and Multiple Sclerosis: Vessels, Barriers of the Brain, and Glymphatics
    Saade, C.
    Bou-Fakhredin, R.
    Yousem, D. M.
    Asmar, K.
    Naffaa, L.
    El-Merhi, F.
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2018, 39 (12) : 2168 - 2176
  • [6] Oxidized phosphatidylcholine is a marker for neuroinflammation in multiple sclerosis brain
    Qin, J.
    Goswami, R.
    Balabanov, R.
    Dawson, G.
    JOURNAL OF NEUROSCIENCE RESEARCH, 2007, 85 (05) : 977 - 984
  • [7] Investigation of cerebral microbleeds in multiple sclerosis as a potential marker of blood-brain barrier dysfunction
    Eisele, Philipp
    Alonso, Angelika
    Griebe, Martin
    Szabo, Kristina
    Hennerici, Michael G.
    Gass, Achim
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2016, 7 : 61 - 64
  • [8] A potential blood based diagnostic marker of multiple sclerosis
    Greenberg, Benjamin M.
    Bigwood, Douglas W.
    Eastman, Eric M.
    Alvares, Christopher P.
    Kaldjian, Eric
    NEUROLOGY, 2008, 70 (11) : A383 - A383
  • [9] The blood-brain barrier in multiple sclerosis
    McQuaid, S
    Kirk, J
    Drug Transport(ers) and the Diseased Brain, 2005, 1277 : 235 - 243
  • [10] CHEMICAL CHANGES IN THE BRAIN AND BLOOD IN MULTIPLE SCLEROSIS
    CUMINGS, JN
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1954, 24 (08) : S60 - S61